Combination Treatment of Intravitreal Ranibizumab, Focal/Grid Laser and Panretinal Photocoagulation in Patients With Diabetic Macula Edema
- Sponsor
- Shinshu University
- Study ID
- NCT02131350
- Phase
- PHASE4
- Status
- Completed
Conditions
- Diabetic Macula Edema
Eligibility Criteria
- Sex
- ALL
- Age
- 20 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Photocoagulation — PROCEDUREPhotocoagulation include focal/grid laser and/or panretinal photocoagulation
- Ranibizumab — DRUG
Study Details
The purpose of this study is to evaluate the mean gain in best corrected visual acuity and the number of intravitreal ranibizumab (IVR) injections under the combination treatment of IVR, focal/grid laser and panretinal photocoagulation. Our hypothesis is that suitable photocoagulation decreases the number of IVR injections.
Key Dates
- First listed
- May 6, 2014
- Start date
- Apr 30, 2014
- Status verified
- Sep 2018
- Primary completion
- Mar 31, 2017
- Completion
- Mar 31, 2018
Study Design
- Enrollment
- 40 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Ranibizumab with Photocoagulation
Primary Outcome Measure
best corrected visual acuity [ Time Frame: every month, up to 36 months ]